Perioperative management of antiplatelet agents in patients with coronary stents: Recommendations of a French Task Force [1]

British Journal of Anaesthesia

Volumn 97, Issue 4, 2006, Pages 580-582

  Albaladejo, P ^a   Marret, E ^a   Piriou, V ^a   Samama, C Marc ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FLURBIPROFEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; TICLOPIDINE;

ANESTHESIOLOGY; CLINICAL PRACTICE; CONSENSUS; CORONARY STENT; DRUG ELUTING STENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOSCOPIC SURGERY; EVIDENCE BASED PRACTICE; FRANCE; HEALTH PRACTITIONER; HIGH RISK PATIENT; HUMAN; LETTER; MEDICAL EXPERT; MEDICAL SOCIETY; MEDICAL SPECIALIST; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURGICAL RISK; TREATMENT PLANNING; WORKSHOP;

EID: 33748852711     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/ael228     Document Type: Letter

References (13)

1. Tam NLK, Pac-Soo C, Pretorius PM. Epidural haematoma after a combined spinal-epidural anaesthetic in a patient treated with clopidogrel and dalteparin. Br J Anaesth 2006; 96: 262-5
2. Spahn DR, Howell SJ, Delabays A, Chassot P-G. Coronary stents and perioperative anti-platelet regimen: Dilemma of bleeding and stent thrombosis. Br J Anaesth 2006; 96: 675-7
3. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and non-cardiac surgery - a prospective outcome study. Br J Anaesth 2006; 96: 686-93
4. Lehot JJ, Piriou V, Durand de Gevigney G, Coriat P. Le patient à risque de thrombose de stent coronaire en période périopératoire: Une situation de plus en plus fréquente. Ann Fr Anesth Réanim 2005; 24: 1247-9
5. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30
6. Rodriguez-Alemparte AE, Mieres J, Fernandez-Pereira C, et al. Coronary stent thrombosis in the current drug eluting stent era: Insights from the ERACI III trial. JACC 2006; 47: 205-7
7. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361-7
8. Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45: 456-9
9. Fléron MH, Dupuis M, Mottet P, Le Feuvre C, Godet G. Chirurgie générale et endoprothèse coronaire: Pensez au sirolimus! Ann Fr Anesth Réanim 2003; 22: 733-5
10. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-21
11. Decoene C, Vincentelli A, Fabre O, Crepin F, Pol A. Thrombose tardive d'une endoprothèse coronaire pharmacoactive après arrêt des agents antiplaquettaires. Ann Fr Anesth Réanim 2005; 24: 1275-7
12. Samama CM, Bastien O, Forestier F, et al. Antiplatelet agents in the perioperative period: Expert recommendations of the French Society of Anesthesiology and Intensive Care (Sfar) 2001 - summary statement. Can J Anaesth 2002; 49: S26-35
13. Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006; 129: 734-73